Literature DB >> 27869917

[Method for projecting indicators for the goals of the Strategic Action Plan for Tackling Chronic Non-Communicable Diseases in Brazil according to Capitals and the Federal District].

Regina Tomie Ivata Bernal1, Deborah Carvalho Malta2, Betine Pinto Moehlecke Iser3, Rosane Aparecida Monteiro4.   

Abstract

OBJECTIVE: to present the indicators' projection method of the Strategic Action Plan for Tackling Chronic Non-Communicable Diseases (NCDs) in Brazilian State capitals and the Federal District, 2012-2022.
METHODS: simple linear regression model was used to calculate the indicators' projections with data from the Surveillance System of Risk and Protective Factors for Chronic Diseases by Telephone Survey (Vigitel).
RESULTS: in most of the capitals, there was an increase in the prevalence of obesity (annual change: 0.36%;1.29%), overweight (annual change: 1.11%;2.00%), recommended (annual change: 1.45%;2.66%) and regular (annual change: 0.45%;1.46%) consumption of fruits and vegetables; smoking presented a decreasing trend (annual change: -1.34%;-0.20%); whereas physical inactivity, heavy drinking and mammography and Pap smears examinations were stable.
CONCLUSION: most of the goals are possible; however, effective actions are necessary, especially for tackling overweight and heavy drinking.

Entities:  

Mesh:

Year:  2016        PMID: 27869917     DOI: 10.5123/S1679-49742016000300002

Source DB:  PubMed          Journal:  Epidemiol Serv Saude        ISSN: 1679-4974


  2 in total

1.  Lifestyle and nutritional status of employees of a chain of banks in Pelotas, Rio Grande do Sul, Brazil.

Authors:  Gabriela Ribeiro Sanchi; Lucia Rota Borges
Journal:  Rev Bras Med Trab       Date:  2020-01-09

2.  A methodology for small area prevalence estimation based on survey data.

Authors:  Regina Tomie Ivata Bernal; Quéren Hapuque de Carvalho; Jill P Pell; Alastair H Leyland; Ruth Dundas; Mauricio Lima Barreto; Deborah Carvalho Malta
Journal:  Int J Equity Health       Date:  2020-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.